Correlation Between Zenas BioPharma, and Humana

Can any of the company-specific risk be diversified away by investing in both Zenas BioPharma, and Humana at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zenas BioPharma, and Humana into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zenas BioPharma, Common and Humana Inc, you can compare the effects of market volatilities on Zenas BioPharma, and Humana and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zenas BioPharma, with a short position of Humana. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zenas BioPharma, and Humana.

Diversification Opportunities for Zenas BioPharma, and Humana

-0.21

Correlation Coefficient

Zenas BioPharma,  Humana

Very good diversification

The 3 months correlation between Zenas and Humana is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Zenas BioPharma, Common and Humana Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humana Inc and Zenas BioPharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zenas BioPharma, Common are associated (or correlated) with Humana. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humana Inc has no effect on the direction of Zenas BioPharma, i.e., Zenas BioPharma, and Humana go up and down completely randomly.

Pair Corralation between Zenas BioPharma, and Humana

Given the investment horizon of 90 days Zenas BioPharma, Common is expected to under-perform the Humana. In addition to that, Zenas BioPharma, is 2.65 times more volatile than Humana Inc. It trades about -0.12 of its total potential returns per unit of risk. Humana Inc is currently generating about -0.05 per unit of volatility. If you would invest  49,288  in Humana Inc on September 21, 2024 and sell it today you would lose (25,303) from holding Humana Inc or give up 51.34% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	13.94%
Values	Daily Returns

Zenas BioPharma, Common  vs.  Humana Inc

Zenas BioPharma, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zenas BioPharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Etf's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the ETF investors.

Humana Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Humana Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Etf's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the ETF investors.

Pair Trading with Zenas BioPharma, and Humana

The main advantage of trading using opposite Zenas BioPharma, and Humana positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zenas BioPharma, position performs unexpectedly, Humana can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humana will offset losses from the drop in Humana's long position.

The idea behind Zenas BioPharma, Common and Humana Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.